Show simple item record

dc.contributor.authorWang, H.
dc.contributor.authorHatzixanthis, K.
dc.contributor.authorBarnard, A.
dc.contributor.authorShah, R.
dc.contributor.authorSaveri, E.
dc.contributor.authorPitts, K.
dc.contributor.authorPiwowarczyk, D.
dc.contributor.authorPatil, G.
dc.contributor.authorBaines, Simon D.
dc.contributor.authorWilkinson, A.
dc.contributor.authorFairhead, H.
dc.identifier.citationWang , H , Hatzixanthis , K , Barnard , A , Shah , R , Saveri , E , Pitts , K , Piwowarczyk , D , Patil , G , Baines , S D , Wilkinson , A & Fairhead , H 2011 , ' SASP: targeted delivery to Gram-negative pathogens ' , 51st Interscience Conf on Antimicrobial Agents and Chemotherapy (ICAAC) , Chicago , United States , 17/09/11 - 20/09/11 .
dc.identifier.otherPURE: 7744061
dc.identifier.otherPURE UUID: eaa09967-4a1f-4143-8d9d-642e2ebd8bae
dc.description.abstractBackground: Gram-negative bacteria are responsible for significant morbidity and mortality worldwide. Multi-drug resistance emergence has rendered many therapies ineffective. New therapies are urgently required to widen treatment options. SASPject technology delivers small acid-soluble spore protein (SASP) genes to target bacteria using modified bacteriophage vectors, resulting in rapid killing. SASP is a unique antibacterial protein that non-specifically binds bacterial DNA and halts DNA replication and gene expression. In this study we present the first data for a Gram-negative targeted SASPject vector (PT3.1) which shows in vitro activity against Escherichia coli (EC) and Pseudomonas aeruginosa (PA). Methods: We evaluated efficacy of SASPject PT3.1 vs. EC (N=5) & PA (N=5) using a microtitre tray fixed duration (3 h) kill method. Log-phase cultures (1x105 cfu/mL) were prepared in supplemented (MgSO4 & CaCl2, 5 mM; glucose, 0.1% w/v) LB broth (LBC) & exposed to 2x108 plaque forming units (pfu)/mL of PT3.1. PT3.1 antimicrobial activity was determined using agar-based culture following incubation (37oC). Additionally, rate of PT3.1 kill was determined using a kill-curve technique; a selection of EC & PA strains from the fixed duration kill study were evaluated & bacterial viable counts determined over 3 h on LBC agar. Results: SASPject PT3.1 elicited good antimicrobial activity vs. EC & PA evaluated in this study; the median reduction in viable counts for PT3.1-treated cultures in the fixed 3 h kill was 99.1%. Kill curve data suggested rapid EC & PA killing; viable counts (log10 cfu/mL range) of PT3.1-treated cultures were 2.36->4.01, 3.04-4.06, and 3.40-4.16 lower than corresponding controls after 1, 2, and 3 h respectively. Conclusions: 1. SASPject PT3.1 demonstrated good antimicrobial activity vs. EC & PA evaluated in this study in a fixed 3 h exposure period 2. PT3.1 was bactericidal (≥3 log10 cfu/mL decline) vs. 3 of 4 isolates (1EC & 2PA) evaluated in time-kill curves after 1 h and against all isolates after 2 h 3. Further evaluations of Gram-negative SASPject phage are warranteden
dc.titleSASP: targeted delivery to Gram-negative pathogensen
dc.contributor.institutionDepartment of Human and Environmental Sciences
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionMicrobiology and Biotechnology
dc.contributor.institutionGeography, Environment and Agriculture
dc.contributor.institutionAgriculture, Food and Veterinary Sciences
dc.contributor.institutionBiosciences Research Group
dc.description.statusNon peer reviewed

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record